Status:
COMPLETED
Family Study of Melanoma in Italy
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
Melanoma
Dysplastic Nevi
Eligibility:
All Genders
10-100 years
Brief Summary
During the course of a case-control study of melanoma conducted at the Bufalini Hospital, Cesena, Italy in the years 1994-1996, 20 families with 2 or 3 melanoma cases were identified and studied. The ...
Detailed Description
To date 557 subjects, including cases of melanoma and unaffected relatives, have been recruited in the family study of melanoma at the Bufalini Hospital, Cesena, Italy, University ofl'Aquila, L'Aquila...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Individuals with the diagnosis of CMM at the Department of Dermatology, Bufalini Hospital, Cesena, Italy who have other family members affected with CMM will be eligible for participation.
Exclusion
Key Trial Info
Start Date :
November 5 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2020
Estimated Enrollment :
1708 Patients enrolled
Trial Details
Trial ID
NCT00339222
Start Date
November 5 2001
End Date
June 30 2020
Last Update
July 1 2020
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
Ospedale Maurizio Bufalini Cesena, Italy
Cessana, Italy, 00/00/00
2
University of Genoa
Genoa, Italy
3
University of L'Aquila
L’Aquila, Italy
4
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy, 1-20133